New treatment approved by the FDA for pancreatic cancer

Easy and affordable genetic testing to learn your BRCA status so you and your healthcare provider can determine what treatment is right for you

Your BRCA status
could determine your
eligibility for advanced
cancer treatments
Only FDA approved
BRCA 1/2 test
Affordable testing
covered by majority of
health plans

BRACAnalysis CDx® Overview

A one size fits all approach in the treatment of cancer can leave the risk of patients being over or under treated. If you or a loved one are diagnosed with metastatic pancreatic, ovarian, or metastatic breast cancer, BRACAnaylsis CDx identifies if you have unique BRCA mutation. Knowing your BRCA status is essential when deciding what treatments are best for you based on the features of your specific cancer.

What is BRCA?

Everyone is born with BRCA genes. Normally, the proteins produced by the BRCA1 and BRCA2 genes prevent cells from developing into cancer. When one of these genes becomes ineffective due to an inherited mutation, the cell can no longer prevent tumors from growing, causing an increased risk for cancer.

Who should consider BRACAnaylsis CDx testing?

Medical Treatment guidelines state the following should receive germline testing1

Breast Cancer
Ovarian Cancer
Pancreatic Cancer

Advanced Cancer Treatments and BRCA

The BRCA genes have historically been analyzed to see if you have a higher risk of developing certain cancers. Recently, researchers have found a new way to use this information to help determine which patients will likely benefit from advanced cancer treatment known as targeted therapies. Cancer cells with a germline BRCA1 and/or BRCA2 mutation are more vulnerable to treatments that directly or indirectly damage DNA. By identifying if you have a BRCA mutation, and use targeted therapies like PARP inhibitor therapy, your cancer cells are less likely to be repaired causing them to die.


BRACAnalysis CDx testing is broadly covered by the vast majority of health plans and with Myriad’s excellent coverage and financial assistance program most appropriate patients pay $0. At Myriad, we believe every patient should have access to the highest quality testing because we know how useful it is in helping healthcare providers deliver the best medical care possible. When one of our tests is ordered for you, we will work with your insurance provider to help you get the appropriate coverage allowed by your plan. If you have questions about billing or coverage, please call Myriad at 800-469-7423 for more details.

Learn More

Process for Testing

With a simple blood test, Myriad can let you and your physician know if you are a candidate for advanced cancer treatment.

1. Your physician takes a blood draw
2. Your sample is sent to Myriad Genetics
3. Myriad sends your results to your physician to share with you. The results indicate your eligibility for targeted therapies

Advanced cancer treatment like targeted therapies are new forms of treatments. Ask your doctor about getting BRCA testing to guide your treatment options.

Fill out the form below to receive a patient guide. If you for some reason don’t receive an email, check your junk folder.


  1. Referenced with permission from the NCCN: Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 3.2019. ©️National Comprehensive Cancer Network, Inc. 2019.